← Leaderboards
William R Meyer
University Of North Carolina Chapel Hill
$1,559,955
Attributed
$1,559,955
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,559,955 · 4
By mechanism
M01$1,559,955 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- John B Buse$71,388,050
- Mary A Dooley$3,689,855
- Kim L Brouwer$15,343,248
- Louis E Underwood$5,889,688
- Karen J Loechner$629,591
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationFemaleClinical TrialsDrug Screening /EvaluationAdrenal DisorderReproductive System Disorder ChemotherapyPostmenopauseAmenorrheaTroglitazonePolycystic Ovary SyndromeEstrogensAndrogensPituitary DisordersOvulationHirsutismHormone TherapyConnective Tissue Disorder ChemotherapySystemic Lupus ErythematosusBlood ChemistryCarbohydrate MetabolismExerciseGonadotropin Releasing Factor
Grant awards (17)
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME$190,747
M01 · FY2002 · RR
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME$294,555
M01 · FY2001 · RR
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME$190,747
M01 · FY2001 · RR
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME$294,555
M01 · FY2000 · RR
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME$294,555
M01 · FY2000 · RR
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME$294,555
M01 · FY2000 · RR
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME$241
M01 · FY2000 · RR
PRESERVING OVARIAN FUNCTION IN LUPUS NEPHRITIS$0
M01 · FY2000 · RR
PRESERVING OVARIAN FUNCTION IN LUPUS NEPHRITIS$0
M01 · FY2000 · RR
EXERCISE ON SERUM ESTROGENS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
EXERCISE ON SERUM ESTROGENS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
EXERCISE ON SERUM ESTROGENS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
EXERCISE ON SERUM ESTROGENS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
ORAL CONTRACEPTIVES AND HORMONAL REPLACEMENT IN SLE$0
M01 · FY2000 · RR
ORAL CONTRACEPTIVES AND HORMONAL REPLACEMENT IN SLE$0
M01 · FY2000 · RR
PRESERVING OVARIAN FUNCTION IN LUPUS NEPHRITIS$0
M01 · FY2000 · RR
ORAL CONTRACEPTIVES AND HORMONAL REPLACEMENT IN SLE$0
M01 · FY2000 · RR